0.635
price down icon5.24%   -0.0351
pre-market  Pre-market:  .64   0.005   +0.79%
loading
Reshape Lifesciences Inc stock is traded at $0.635, with a volume of 271.35K. It is down -5.24% in the last 24 hours and down -75.00% over the past month. Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.
See More
Previous Close:
$0.6701
Open:
$0.69
24h Volume:
271.35K
Relative Volume:
0.28
Market Cap:
$2.10M
Revenue:
$9.81M
Net Income/Loss:
$-26.16M
P/E Ratio:
-0.0164
EPS:
-38.77
Net Cash Flow:
$-17.45M
1W Performance:
-33.28%
1M Performance:
-75.00%
6M Performance:
-93.48%
1Y Performance:
-93.74%
1-Day Range:
Value
$0.626
$0.69
1-Week Range:
Value
$0.626
$0.9508
52-Week Range:
Value
$0.626
$29.00

Reshape Lifesciences Inc Stock (RSLS) Company Profile

Name
Name
Reshape Lifesciences Inc
Name
Phone
949-429-6680
Name
Address
1001 CALLE AMANECER, SAN CLEMENTE
Name
Employee
31
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
RSLS's Discussions on Twitter

Compare RSLS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
RSLS
Reshape Lifesciences Inc
0.635 2.10M 9.81M -26.16M -17.45M -38.77
Medical Devices icon
ABT
Abbott Laboratories
129.89 225.27B 41.95B 13.40B 6.35B 7.65
Medical Devices icon
BSX
Boston Scientific Corp
95.37 140.74B 16.75B 1.85B 2.37B 1.25
Medical Devices icon
SYK
Stryker Corp
363.66 138.77B 22.60B 2.99B 3.49B 7.76
Medical Devices icon
MDT
Medtronic Plc
92.33 118.39B 33.20B 4.26B 5.47B 3.29
Medical Devices icon
EW
Edwards Lifesciences Corp
67.95 39.95B 5.72B 4.17B 259.90M 6.97

Reshape Lifesciences Inc Stock (RSLS) Latest News

pulisher
Mar 12, 2025

ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Growth Last Week - MSN

Mar 12, 2025
pulisher
Mar 12, 2025

First national perception survey of Food is Medicine programs shows strong public support - EurekAlert

Mar 12, 2025
pulisher
Mar 11, 2025

Ratio Analysis: Unpacking ReShape Lifesciences Inc (RSLS)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Mar 11, 2025
pulisher
Mar 10, 2025

ReShape Lifesciences, Allarity, Exact Sciences, CVS, AbbVie: 5 Health Care Stocks That Led Retail Message Grow - Asianet Newsable

Mar 10, 2025
pulisher
Mar 10, 2025

ReShape Lifesciences® Receives Notice of Allowance for U.S. - GlobeNewswire

Mar 10, 2025
pulisher
Mar 10, 2025

ReShape Lifesciences Patents Breakthrough Diabetes Neuromodulation System - StockTitan

Mar 10, 2025
pulisher
Mar 09, 2025

ReShape Lifesciences, Inc. to Host Earnings Call - ACCESS Newswire

Mar 09, 2025
pulisher
Mar 07, 2025

RSLS stock touches 52-week low at $0.87 amid market challenges - Investing.com Canada

Mar 07, 2025
pulisher
Mar 07, 2025

RSLS stock touches 52-week low at $0.87 amid market challenges By Investing.com - Investing.com South Africa

Mar 07, 2025
pulisher
Mar 06, 2025

Global Synthetic Biosensors Market Size to Hit USD 49.87 Billion by 2032 -Coherent Market Insights - openPR

Mar 06, 2025
pulisher
Mar 01, 2025

Minimally Invasive Bariatric Surgery Equipment Market Accelerating Digital Transformation for a Smarter Future - ExpressVartha

Mar 01, 2025
pulisher
Feb 28, 2025

RSLS Stock Touches 52-Week Low at $0.99 Amid Market Challenges - Investing.com Canada

Feb 28, 2025
pulisher
Feb 28, 2025

RSLS Stock Touches 52-Week Low at $0.99 Amid Market Challenges By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 28, 2025

Pre-market Movers: BTAI, VRPX, DCGO, NBY... - RTTNews

Feb 28, 2025
pulisher
Feb 26, 2025

Icahn Enterprises Earnings: What To Look For From IEP - The Globe and Mail

Feb 26, 2025
pulisher
Feb 25, 2025

Corcept (CORT) Q4 Earnings Report Preview: What To Look For - The Globe and Mail

Feb 25, 2025
pulisher
Feb 25, 2025

Volatus Aerospace and Ondas Holdings Forge Strategic Partnership to Elevate Border Surveillance with Advanced Drone Technologies - The Manila Times

Feb 25, 2025
pulisher
Feb 25, 2025

ReShape Lifesciences® Signs Distribution Agreement in - GlobeNewswire

Feb 25, 2025
pulisher
Feb 25, 2025

Can ReShape's New Canadian Partnership Transform Its Weight Loss Device Sales? - StockTitan

Feb 25, 2025
pulisher
Feb 25, 2025

Liverpool City Region orders 58 next-generation Enviro400EV zero-emission double deckers from NFI subsidiary Alexander Dennis - The Globe and Mail

Feb 25, 2025
pulisher
Feb 19, 2025

Why Global Blue Group Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - NewsBreak

Feb 19, 2025
pulisher
Feb 19, 2025

“Technology Stocks to Watch: CSDX, LYT, SINT, TRNR, RSLS, CYCU, TRUG Market Momentum Building” - The Globe and Mail

Feb 19, 2025
pulisher
Feb 18, 2025

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.02% - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

United States shares higher at close of trade; Dow Jones Industrial Average up 0.02% - Investing.com India

Feb 18, 2025
pulisher
Feb 18, 2025

12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga

Feb 18, 2025
pulisher
Feb 18, 2025

ReShape Lifesciences prices $6M public offering - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

Why GCL Global Holdings Shares Are Trading Higher By Around 107%; Here Are 20 Stocks Moving Premarket - Benzinga India

Feb 18, 2025
pulisher
Feb 15, 2025

ReShape Lifesciences Raises Fresh Capital: $6M Strategic Financing Deal Unveiled - StockTitan

Feb 15, 2025
pulisher
Feb 15, 2025

Reshape Lifesciences Says Pricing Of Upsized $6.0 Million Public Offering -February 15, 2025 at 11:18 pm EST - Marketscreener.com

Feb 15, 2025
pulisher
Feb 15, 2025

ReShape Lifesciences® Announces Pricing of Upsized $6.0 Million Public Offering - Yahoo Finance

Feb 15, 2025
pulisher
Feb 15, 2025

ReShape Lifesciences® Prices Public Offering of 2,575,107 Units at $2.33 Each - Nasdaq

Feb 15, 2025
pulisher
Feb 14, 2025

RSLS stock touches 52-week low at $2.57 amid market challenges - Investing.com Nigeria

Feb 14, 2025
pulisher
Feb 13, 2025

RSLS stock touches 52-week low at $2.57 amid market challenges By Investing.com - Investing.com South Africa

Feb 13, 2025
pulisher
Feb 13, 2025

ReShape Lifesciences secures key diabetes treatment patent - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

Vagus Nerve Stimulators Market Witness Growth: Booming Demand, - openPR

Feb 13, 2025
pulisher
Feb 11, 2025

Key Trend Revolutionizing the Bariatric Surgery Devices Market in 2025: Olympus Fully Launches Next-Level S... - WhaTech

Feb 11, 2025
pulisher
Feb 10, 2025

Synthetic Biosensors Market: Trends, Applications & Growth - openPR

Feb 10, 2025
pulisher
Feb 09, 2025

CPI, Powell Testimony and Other Can't Miss Items this Week - The Globe and Mail

Feb 09, 2025
pulisher
Feb 07, 2025

Why Amazon Could Be the Best Big Tech Investment of Q1 - The Globe and Mail

Feb 07, 2025
pulisher
Feb 06, 2025

AI and Automation reshape revenue management in the Life Sciences industry - ETHealthWorld

Feb 06, 2025
pulisher
Feb 06, 2025

Emera Incorporated Announces Results of Series F First Preferred Share Conversion - The Globe and Mail

Feb 06, 2025
pulisher
Feb 05, 2025

Accuray (ARAY) Stock Surges Amidst Market Activity - GuruFocus.com

Feb 05, 2025
pulisher
Feb 05, 2025

Earnings To Watch: e.l.f. Beauty (ELF) Reports Q4 Results Tomorrow - The Globe and Mail

Feb 05, 2025
pulisher
Feb 04, 2025

ReShape Lifesciences receives international patent in Israel for its proprietary diabetes neuromodulation technology; shares rise - MSN

Feb 04, 2025
pulisher
Feb 03, 2025

ReShape Lifesciences® Granted Key International Patent in - GlobeNewswire

Feb 03, 2025
pulisher
Feb 03, 2025

Groundbreaking Diabetes Tech Patent Win: ReShape's Neural Solution Could Eliminate Daily Medications - StockTitan

Feb 03, 2025

Reshape Lifesciences Inc Stock (RSLS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_devices ZBH
$107.57
price up icon 3.40%
medical_devices STE
$222.45
price down icon 0.89%
medical_devices PHG
$26.11
price down icon 2.03%
$68.48
price down icon 3.22%
$81.45
price down icon 2.79%
medical_devices EW
$67.95
price down icon 0.82%
Cap:     |  Volume (24h):